DNA methylation: conducting the orchestra from exposure to phenotype?
DNA methylation, through 5-methyl- and 5-hydroxymethylcytosine (5mC and 5hmC), is considered to be one of the principal interfaces between the genome and our environment, and it helps explain phenotypic variations in human populations. Initial reports of large differences in methylation level in genomic regulatory regions, coupled with clear gene expression data in both imprinted genes and malignant diseases, provided easily dissected molecular mechanisms for switching genes on or off. However, a more subtle process is becoming evident, where small (<10 %) changes to intermediate methylation levels are associated with complex disease phenotypes. This has resulted in two clear methylation paradigms. The latter "subtle change" paradigm is rapidly becoming the epigenetic hallmark of complex disease phenotypes, although we are currently hampered by a lack of data addressing the true biological significance and meaning of these small differences. Our initial expectation of rapidly identifying mechanisms linking environmental exposure to a disease phenotype led to numerous observational/association studies being performed. Although this expectation remains unmet, there is now a growing body of literature on specific genes, suggesting wide ranging transcriptional and translational consequences of such subtle methylation changes. Data from the glucocorticoid receptor (NR3C1) has shown that a complex interplay between DNA methylation, extensive 5'UTR splicing, and microvariability gives rise to the overall level and relative distribution of total and N-terminal protein isoforms generated. Additionally, the presence of multiple AUG translation initiation codons throughout the complete, processed mRNA enables translation variability, hereby enhancing the translational isoforms and the resulting protein isoform diversity, providing a clear link between small changes in DNA methylation and significant changes in protein isoforms and cellular locations. Methylation changes in the NR3C1 CpG island alters the NR3C1 transcription and eventually protein isoforms in the tissues, resulting in subtle but visible physiological variability. This review addresses the current pathophysiological and clinical associations of such characteristically small DNA methylation changes, the ever-growing roles of DNA methylation and the evidence available, particularly from the glucocorticoid receptor of the cascade of events initiated by such subtle methylation changes, as well as addressing the underlying question as to what represents a genuine biologically significant difference in methylation.
Department of Infection and Immunity, Luxembourg Institute of Health, 29 rue Henri Koch, 4354 Esch-sur-Alzette, Luxembourg ; Department of Immunology, Research Institute of Psychobiology, University of Trier, 54290 Trier, Germany.
Fleur A D
FA
Leenen
Department of Infection and Immunity, Luxembourg Institute of Health, 29 rue Henri Koch, 4354 Esch-sur-Alzette, Luxembourg ; Department of Immunology, Research Institute of Psychobiology, University of Trier, 54290 Trier, Germany.
Claude P
CP
Muller
Department of Infection and Immunity, Luxembourg Institute of Health, 29 rue Henri Koch, 4354 Esch-sur-Alzette, Luxembourg.
Jonathan D
JD
Turner
D020121:5' Untranslated Regions; D044503:5-Methylcytosine / Q000031:analogs & derivatives / Q000378:metabolism; D018899:CpG Islands; D019175:DNA Methylation; D004781:Environmental Exposure; D044127:Epigenesis, Genetic; D015870:Gene Expression; D005786:Gene Expression Regulation; D006801:Humans; D010641:Phenotype; D020033:Protein Isoforms / Q000235:genetics; D011965:Receptors, Glucocorticoid / Q000235:genetics*
D020121:5' Untranslated Regions; C497713:NR3C1 protein, human; D020033:Protein Isoforms; D011965:Receptors, Glucocorticoid; C011865:5-hydroxymethylcytosine; D044503:5-Methylcytosine
Association studies; Biomarker; DNA methylation; EWAS; Gene-environment interactions; Transcriptional microvariability